Spiriva Handihaler
Spiriva Handihaler is an anticholinergic bronchodilator containing tiotropium bromide. It is designed for oral inhalation only using the Handihaler device. It works by relaxing and opening the airways to the lungs, making it easier to breathe for patients with COPD. The capsules must only be inhaled using the device and should never be swallowed.
Dosage by Body Weight
The standard adult dose is the inhalation of the powder contents of one Spiriva capsule once daily, at the same time each day, using the HandiHaler inhalation device. Do not swallow the capsules.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group. |
| 5-7 kg | Not recommended | Do not use | Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group. |
| 8-10 kg | Not recommended | Do not use | Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group. |
| 11-15 kg | Not recommended | Do not use | Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group. |
| 16-20 kg | Not recommended | Do not use | Safety and effectiveness of Spiriva Handihaler have not been established in pediatric patients. Not indicated for this weight group. |
Formulation
Purpose
Long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and for reducing COPD exacerbations.
Generic Name
Tiotropium bromideScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.